Ensysce Biosciences, Inc. - 8-K Filing
Ensysce Biosciences received a delisting notice from Nasdaq on May 21, 2026, for failing to meet the $2.5 million stockholders’ equity requirement under Listing Rule 5550(b)(1) as of March 31, 2026. The company has until July 6, 2026, to submit a plan to regain compliance and may receive an extension if approved. (Items: 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing On May 21, 2026, Ensysce Biosciences Inc)
Tickers: $ENSC